Author:
Gleave Martin,Miyake Hideaki,Chi Kim
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference78 articles.
1. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD (1993) Effects of intermittent androgen suppression on androgen-dependent tumours: apoptosis and serum prostate specific antigen. Cancer 71:2782–2790
2. Albain K, Green S, Ravdin P, Cobau CD, Levine EG, Ingle JN, Pritchard KI, Schneider DJ, Abeloff MD, Norton L, Henderson IC, Lew D, Livingston RB, Martino S, Osborne CK (2002) Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: initial results from intergroup trial 0100 (SWOG-8814) (abstract 143). Proc Am Soc Clin Oncol 21:36a
3. Albrecht W, Collette L, Fava C, Kariakine OB, Whelan P, Studer UE, De Reijke TM, Kil PJ, Rea LA (2003) Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study. Eur Urol 44:505–511
4. Arriagada R, Le M, Spielmann M, Mauriac L, Bonneterre J, Namer M, Hill C, Tursz T (2003) Randomized trial of adjuvant ovarian suppression in 926 patients with early breast cancer treated with adjuvant chemotherapy (abstract 14). Proc Am Soc Clin Oncol 22:4a
5. Bolla M, Gonzalez MD, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295–300
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献